|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,565.00 ARS | -1.88% |
|
-1.57% | -20.76% |
| Market Cap | 126B 88.01M 75.92M 69.8M 65.7M 123M 8.31B 124M 827M 322M 4.08B 330M 323M 14.1B | P/E 2024 |
6.08x | P/E 2025 | 51.6x |
|---|---|---|---|---|---|
| Enterprise Value | 357B 249M 215M 197M 186M 349M 23.49B 352M 2.34B 911M 11.53B 934M 914M 39.88B | EV / Sales 2024 |
3.04x | EV / Sales 2025 | 3.08x |
| Free-Float |
17.54% | Yield 2024 |
1.5% | Yield 2025 | - |
| 1 day | -1.88% | ||
| 1 week | -1.57% | ||
| Current month | -4.57% | ||
| 1 month | -1.88% | ||
| 3 months | -9.01% | ||
| 6 months | -24.76% | ||
| Current year | -20.76% |
| 1 week | 1,530 | 1,640 | |
| 1 month | 1,520 | 1,725 | |
| Current year | 1,420 | 2,130 | |
| 1 year | 945 | 2,300 | |
| 3 years | 480.5 | 2,300 | |
| 5 years | 208.5 | 2,300 | |
| 10 years | 24.8 | 2,300 |
| Manager | Title | Age | Since |
|---|---|---|---|
| President | - | - | |
| General Counsel | - | 29/04/2025 | |
| Corporate Officer/Principal | - | 29/04/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | - | - | |
| Director/Board Member | - | - | |
| Director/Board Member | - | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -1.88% | -1.57% | +7.93% | +205.07% | 88.16M | ||
| -0.62% | -1.94% | +40.83% | +146.56% | 1,001B | ||
| -0.67% | -2.09% | +53.24% | +42.27% | 566B | ||
| -0.45% | -1.52% | +19.44% | +60.74% | 393B | ||
| +3.82% | +2.29% | +24.04% | +16.53% | 326B | ||
| +1.09% | +1.65% | +26.61% | +33.19% | 276B | ||
| +1.42% | +0.06% | +26.36% | +15.68% | 277B | ||
| +1.87% | +0.87% | -41.49% | -47.26% | 193B | ||
| -0.96% | +1.95% | +18.71% | +50.63% | 188B | ||
| -1.11% | +3.74% | +16.69% | +62.17% | 158B | ||
| Average | -0.25% | +0.16% | +19.24% | +58.56% | 337.69B | |
| Weighted average by Cap. | -0.26% | -0.41% | +29.40% | +66.22% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 91.79B 63.92M 55.15M 50.7M 47.72M 89.67M 6.03B 90.43M 601M 234M 2.96B 240M 235M 10.24B | 127B 88.25M 76.13M 69.99M 65.88M 124M 8.33B 125M 829M 323M 4.09B 331M 324M 14.14B |
| Net income | 23.85B 16.61M 14.33M 13.17M 12.4M 23.29M 1.57B 23.49M 156M 60.77M 769M 62.32M 60.99M 2.66B | 3.09B 2.15M 1.86M 1.71M 1.61M 3.02M 203M 3.04M 20.21M 7.87M 99.6M 8.07M 7.9M 345M |
| Net Debt | 134B 93.07M 80.29M 73.82M 69.48M 131M 8.78B 132M 875M 341M 4.31B 349M 342M 14.91B | 231B 161M 139M 128M 120M 226M 15.18B 228M 1.51B 589M 7.45B 604M 591M 25.78B |
Employees
620
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 16/06/26 | 1,565.00 $ | -1.88% | 4,012 |
| 12/06/26 | 1,595.00 $ | -1.85% | 2,362 |
| 11/06/26 | 1,625.00 $ | +1.88% | 2,208 |
| 10/06/26 | 1,595.00 $ | +0.31% | 5,402 |
| 09/06/26 | 1,590.00 $ | -0.31% | 35,894 |
- Stock Market
- Stocks
- RICH Stock
Select your edition
All financial news and data tailored to specific country editions
















